Velpatasvir - Isotope Labelled Standards
References
FAQ's
References
- Bacon, Elizabeth M.; Cottell, Jeromy J.; Katana, Ashley Anne; Kato, Darryl; Krygowski, Evan S.; Link, John O.; Taylor, James; Tran, Chinh Viet; Trejo Martin, Teresa Alejandra; Yang, Zheng-Yu; et al, Antiviral Compounds, WO2012068234A2, May 24, 2012
- Nalla, Sarath; Seshagiri, Rao J. V. L. N., A stability indicating RP-HPLC method for simultaneous estimation of velpatasvir and sofosbuvir in combined tablet dosage forms, World Journal of Pharmacy and Pharmaceutical Sciences, Volume: 6, Issue: 9, Pages: 1596-1611, 2017
Frequently Asked Questions
Are Velpatasvir impurities tested for potential toxicity?
Yes, impurities in Velpatasvir undergo toxicity testing to assess their potentially harmful effects. The tests help determine their safety profile and establish acceptable limits to ensure patient safety.
How can patients ensure the quality of the Velpatasvir they receive?
Patients can ensure the quality of Velpatasvir by obtaining the medication from reputable sources, such as licensed pharmacies or healthcare providers. Following the prescribed dosage and consulting healthcare professionals during treatment is essential.
Which analytical methods help in analyzing Velpatasvir impurities?
High-performance liquid chromatography (HPLC) is employed to separate and analyze the impurities of Velpatasvir.
How should Velpatasvir impurities be stored in terms of temperature?
The recommendation is to store Velpatasvir impurities at room temperature, within 2-8 °C.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.